Loading
Every trade that managers of ネクセラファーマ(株) disclose to EDINET (Japan FSA) is tracked on this page. In the past year (18 October 2025 to 18 October 2026), 4 filings came from 1 insider.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
There has been no open-market purchase by an insider of ネクセラファーマ(株) for at least a year. Typically, a trade is published a median of 7 days after it takes place. This delay matters because a trade only becomes useful information once it is public.
Across the 3,423 companies tracked on its exchange, the median is 3 filings; at 4 filings, this issuer sits above that mark.
These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
· cache
5 of 5 declarations
Nexela Pharma Co., Ltd. is a Japanese company listed on the Tokyo Stock Exchange, specializing in the pharmaceutical sector. It focuses on the development of innovative treatments and health solutions.